Home › Bronchiolitis Obliterans Syndrome › Pennsylvania › Philadelphia
Bronchiolitis Obliterans Syndrome clinical trials in Philadelphia, PA
6 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
RecruitingPhase 3
- Jefferson University Hospitals, Philadelphia
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
RecruitingPhase 2
- Fox Chase Cancer Center, Philadelphia
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
RecruitingPhase 1/2Healthy volunteers welcome
- Hospital of the University of Pennsylvania, Philadelphia
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RecruitingPhase 3
- University of Pennsylvania, Philadelphia
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
Recruiting
- Temple Digestive Disease Center, Philadelphia
Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord Injury
Recruiting
- Thomas Jefferson University Center City Campus, Philadelphia
Bronchiolitis Obliterans Syndrome trials in other cities
- Boston, MA13 studies
- Seattle, WA11 studies
- Atlanta, GA10 studies
- New York City, NY9 studies
- Houston, TX8 studies
- Los Angeles, CA7 studies
- Miami, FL7 studies
- Baldwin Park, CA6 studies
- Tampa, FL6 studies
- Durham, NC6 studies
- Washington, DC6 studies
- San Francisco, CA5 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.